Optimizing the management of patients with spinal myeloma disease.
Molloy S et al. Br J Haematol. 2015 Jul 17. doi: 10.1111/bjh.13577. [Epub ahead of print].
Measuring therapy-induced peripheral neuropathy: preliminary development and validation of the Treatment-induced Neuropathy Assessment Scale (TNAS).
Mendoza TR et al. J Pain. 2015 Jul 22. pii: S1526-5900(15)00763-4. doi: 10.1016/j.jpain.2015.07.002. [Epub ahead of print].
High-dose therapy improves the bone remodelling compartment canopy coverage and bone formation in multiple myeloma.
Hinge M et al. Br J Haematol. 2015 Jul 27. doi: 10.1111/bjh.13584. [Epub ahead of print]
Thrombosis in Lymphoma Patients and in Myeloma Patients.
Yokoyama K. Keio J Med. 2015 Jul 25. [Epub ahead of print].
Rare Synchronous Gastrointestinal Plasmacytomas of Colon and Stomach.
Syal G et al. ACG Case Rep J. 2015 Jul 9;2(4):224-6. doi: 10.14309/crj.2015.66. eCollection 2015.
Incidence of infection according to intravenous immunoglobulin (IVIG) use in autologous hematopoietic stem cell transplant recipients with multiple myeloma.
Park S et al. Transpl Infect Dis. 2015 Jul 22. doi: 10.1111/tid.12424. [Epub ahead of print].
Pomalidomide-Induced Pulmonary Toxicity in Multiple Myeloma.
Modi D et al. Am J Med Sci. 2015 Jul 21. [Epub ahead of print].
A virtual approach to evaluate therapies for management of multiple myeloma induced bone disease.
Ji B et al. Int J Numer Method Biomed Eng. 2015 Jul 21. doi: 10.1002/cnm.2735. [Epub ahead of print].
Family history of venous thromboembolism and risk of hospitalized thromboembolism in cancer patients: A nationwide family study.
Zöller B et al. Thromb Res. 2015 Jul 14. pii: S0049-3848(15)30056-6. doi: 10.1016/j.thromres.2015.07.004. [Epub ahead of print].
Significance of the detection of paroxysmal nocturnal hemoglobinuria clones in patients with multiple myelomaundergoing autologous stem cell transplantation.
Chatziantoniou V et al. Hematol Oncol Stem Cell Ther. 2015 Jul 9. pii: S1658-3876(15)00060-6. doi: 10.1016/j.hemonc.2015.06.008. [Epub ahead of print].
Silent venous thromboembolism in multiple myeloma patients treated with lenalidomide.
Isoda A et al. Int J Hematol. 2015 Jul 16. [Epub ahead of print].
CT-based Structural Rigidity Analysis Is More Accurate Than Mirels Scoring for Fracture Prediction in Metastatic Femoral Lesions.
Damron TA et al. Clin Orthop Relat Res. 2015 Jul 14. [Epub ahead of print].
Three patients with multiple myeloma developing secondary lymphoblastic leukemia: case reports and review of the literature.
Junxun L et al. Tumori. 2015 Jul 2;0(0):0. doi: 10.5301/tj.5000377. [Epub ahead of print].
Extramedullary relapse of multiple myeloma presenting as massive upper gastrointestinal bleeding: a rare complication.
Yasar B et al. Korean J Intern Med. 2015 Jul;30(4):538-9. doi: 10.3904/kjim.2015.30.4.538. Epub 2015 Jun 29.
Reversible diabetes insipidus in a patient with multiple myeloma.
Shand JA et al. N Z Med J. 2015 Jul 3;128(1417):52-4.
Neutrophilic leukemoid reaction in multiple myeloma.
Milojkovic D et al. Am J Hematol. 2015 Jul 6. doi: 10.1002/ajh.24106. [Epub ahead of print].
Cryofibrinogenaemia in a patient with multiple myeloma and necrotizing vasculitis.
Velasco-Rodríguez D et al. Br J Haematol. 2015 Jul 6. doi: 10.1111/bjh.13569. [Epub ahead of print].
Bortezomib-induced acute interstitial nephritis.
Cheungpasitporn W et al. Nephrol Dial Transplant. 2015 Jul;30(7):1225-9. doi: 10.1093/ndt/gfv222.
Multiple Myeloma and Abdominal Aortic Aneurysm on Myocardial Perfusion Raw Images.
Ghaedian T et al. Clin Nucl Med. 2015 Jul 28. [Epub ahead of print].
Obstructive Jaundice as Initial Presentation of Multiple Myeloma: Case Presentation and Literature Review.
Khan Y et al. Case Rep Med. 2015;2015:686210. doi: 10.1155/2015/686210. Epub 2015 Jun 21.